AI powered DNA Testing

Ares Genetics’ combines Next Generation Sequencing (NGS) with ARESdb, the world‘s most comprehensive database on the genetics of antibiotic resistance.

AI powered DNA Testing

Ares Genetics’ combines Next Generation Sequencing (NGS) with ARESdb, the world‘s most comprehensive database on the genetics of antibiotic resistance.

ARESdb

ARESdb contains thousands of whole genome sequenced clinical isolates collected from more than 200 centers globally. ARESdb combines broad resistance profiles with high-quality their genetic information and enables pathogen identification with up to >99% accuracy and antibiotic resistance detection with up to more than 98%.

Global DB

ARESdb covers 30 years of emerging antibiotic resistance to accurately detect AMR.

>150 Digital AMR Panels

ARESdb is the world’s largest database of genetic antibiotic resistance markers and predictive AMR panels.

Broad Pathogen Coverage

ARESdb combines deep whole-genome sequencing data with antibiotic resistance profiles and is continuously expanded.

ARES Platform

Our proprietary digital health platform combines a NGS-based Universal Pathogenome Assay (ARESupa) with a cloud based decision support & reporting system (AREScds) that is sustainably keeping pace with rapidly evolving AMR based on an Artificial Intelligence powered in-vitro diagnostics (IVD) Reference Database (ARESdb).

ARESdb

Most comprehensive, global and continuously updated proprietary knowledgebase on genetic antibiotic resistance marker and their diagnostic relevance.

Powered by AI

Semi-automated resistance marker discovery, prioritization and validation engine. AI-informed database expansion from structured and unstructured AMR data to diagnostics markers based on expert-defined evidence levels.

ARESupa

Universal Pathogenome Assay (UPA) for any patient sample.

AREScds

Secure & HIPAA compliant cloud-based Clinical Decision Support system (CDS) linking AMR markers to treatment response.